DrugPatentWatch Database Preview
Chartwell Molecular Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for CHARTWELL MOLECULAR, and what generic and branded alternatives to CHARTWELL MOLECULAR drugs are available?
CHARTWELL MOLECULAR has nine approved drugs.
There is one tentative approval on CHARTWELL MOLECULAR drugs.
Summary for Chartwell Molecular
| US Patents: | 0 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 9 |
Drugs and US Patents for Chartwell Molecular
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Molecular | RISPERIDONE | risperidone | TABLET;ORAL | 077543-006 | May 18, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Chartwell Molecular | RAMIPRIL | ramipril | CAPSULE;ORAL | 078745-002 | Jun 18, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Chartwell Molecular | CITALOPRAM HYDROBROMIDE | citalopram hydrobromide | TABLET;ORAL | 077044-002 | Nov 5, 2004 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Chartwell Molecular | RISPERIDONE | risperidone | TABLET;ORAL | 077543-002 | May 18, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Chartwell Molecular | CITALOPRAM HYDROBROMIDE | citalopram hydrobromide | TABLET;ORAL | 077044-001 | Nov 5, 2004 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
